China National MedicinesSHSE:600511 +1.62%86 OCF Yield % is 1.50 as of Jul. 04, 2026, which is 75% below its 10-year median of 6.11. GuruFocus rates SHSE:600511 with a GF Score™ of 86/100 and a GF Value™ of ¥32.74 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 117 Medical Distribution companies, China National Medicines ranks worse than 67.52% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
China National Medicines OCF Yield % Related Terms
China National Medicines OCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:600511 vs MCK, CAH, COR: OCF Yield % Comparison
For the Medical Distribution subindustry, China National Medicines's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China National Medicines OCF Yield % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, China National Medicines's OCF Yield % distribution charts can be found below:
* The bar in red indicates where China National Medicines's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China National Medicines (SHSE:600511) has a OCF Yield % of 1.50 as of Jul. 04, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on China National Medicines and its competitors. This is 75% below median its historical median of 6.11. According to the industry distribution chart, China National Medicines ranks #79 out of 117 companies in the Medical Distribution industry, placing it in the top 67.5%.
Is China National Medicines' OCF Yield % too high?
China National Medicines' current OCF Yield % of 1.50 is 75% below median its 10-year median of 6.11. The Medical Distribution industry median OCF Yield % is 5.87. China National Medicines' value of 1.50 is 74.4% below this industry median. Based on the distribution chart, China National Medicines ranks #79 out of 117 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, China National Medicines has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does China National Medicines' OCF Yield % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, China National Medicines ranks #79 out of 117 companies for OCF Yield %. This places China National Medicines in the lower half of its industry. The industry median OCF Yield % is 5.87. China National Medicines' value of 1.50 is 74.4% below this benchmark. While the company's 10-year median is 6.11 vs. the industry median of 5.87, China National Medicines has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Distribution company?
The median OCF Yield % among Medical Distribution companies is 5.87, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China National Medicines's current OCF Yield % of 1.50 is 74.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on China National Medicines and its competitors. For the Medical Distribution industry, the median OCF Yield % is 5.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China National Medicines's current OCF Yield % is 1.50, which is 75% below median its own 10-year median of 6.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China National Medicines stock overvalued right now?
Based on GuruFocus' analysis, China National Medicines (SHSE:600511) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥32.74, compared to a current price of ¥26.94 — trading 17.7% below its estimated fair value. The current OCF Yield % is 1.50, which is 75% below median its 10-year median of 6.11 and 74.4% below the Medical Distribution industry median of 5.87. China National Medicines' overall GF Score™ is 86/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For China National Medicines (SHSE:600511), the current OCF Yield % is 1.50 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China National Medicines (SHSE:600511) Overvalued in 2026?
Based on GuruFocus' analysis, China National Medicines stock appears to be undervalued.
The current stock price of ¥26.94 is trading 17.7% below its estimated GF Value™ of ¥32.74.
GuruFocus considers China National Medicines to be Modestly Undervalued.
Key valuation signals for SHSE:600511:
OCF Yield %: 1.50 (75% below median its 10-year median of 6.11)
GF Value™: ¥32.74 vs. price of ¥26.94 (17.7% below fair value)
Industry Position: 74.4% below the Medical Distribution median (#79 of 117)
No single metric tells the full story. See the SHSE:600511 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China National Medicines Corp Ltd focuses on producing special drugs and high-end prescription drugs. Its main goal is to provide customers with professional medical services. The company conducts its operations through two primary segments. The Commercial segment is mainly engaged in the sale of pharmaceuticals. The Others segment focuses on pharmaceutical manufacturing and logistics operations.
86GF Score
Get the complete analysis for SHSE:600511
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600511 has been successfully added to your 
